SYK - Stryker Corporation
NYSE
->
Healthcare
->
Medical Devices
Kalamazoo,
United States
Type: Equity
SYK price evolution
SYK
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1874 | $2330 | $2971 | |
| Short term investments | $83 | $77 | $82 | |
| Net receivables | $3736 | $3622 | $3473 | $3765 |
| Inventory | $5292 | $5044 | $5026 | $4843 |
| Total current assets | $14673 | $11645 | $11892 | $12487 |
| Long term investments | ||||
| Property, plant & equipment | $3945 | $3318 | $3785 | $3215 |
| Goodwill & intangible assets | $19771 | $19860 | $19836 | |
| Total noncurrent assets | $27485 | $27510 | $27394 | |
| Total investments | $83 | $77 | $82 | |
| Total assets | $43833 | $39130 | $39402 | $39881 |
| Current liabilities | ||||
| Accounts payable | $1337 | $1304 | $1246 | $1517 |
| Deferred revenue | ||||
| Short long term debt | $2095 | $2058 | $2094 | |
| Total current liabilities | $7669 | $6926 | $6955 | $7890 |
| Long term debt | $13325 | $10127 | $10807 | $10901 |
| Total noncurrent liabilities | $12442 | $13275 | $13398 | |
| Total debt | $12222 | $12865 | $12995 | |
| Total liabilities | $23684 | $19368 | $20230 | $21288 |
| Shareholders' equity | ||||
| Retained earnings | $18303 | $17774 | $17254 | $16771 |
| Other shareholder equity | -$545 | -$355 | -$377 | $18593 |
| Total shareholder equity | $19762 | $19172 | $18593 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2971 | $1844 | $2944 | $2943 |
| Short term investments | $82 | $84 | $75 | $81 |
| Net receivables | $3765 | $3565 | $3022 | $2701 |
| Inventory | $4843 | $3995 | $3314 | $3494 |
| Total current assets | $12487 | $10275 | $10017 | $9707 |
| Long term investments | ||||
| Property, plant & equipment | $3215 | $2970 | $2833 | $2752 |
| Goodwill & intangible assets | $19836 | $19765 | $17758 | $18332 |
| Total noncurrent assets | $27394 | $26609 | $24614 | $24623 |
| Total investments | $82 | $84 | $75 | $81 |
| Total assets | $39881 | $36884 | $34631 | $34330 |
| Current liabilities | ||||
| Accounts payable | $1517 | $1413 | $1129 | $810 |
| Deferred revenue | ||||
| Short long term debt | $2094 | $1191 | $7 | $761 |
| Total current liabilities | $7890 | $6303 | $4549 | $5041 |
| Long term debt | $10901 | $11857 | $12472 | $13230 |
| Total noncurrent liabilities | $13398 | $13965 | $15205 | $16205 |
| Total debt | $12995 | $13048 | $12479 | $13991 |
| Total liabilities | $21288 | $20268 | $19754 | $21246 |
| Shareholders' equity | ||||
| Retained earnings | $16771 | $14765 | $13480 | $12462 |
| Other shareholder equity | $18593 | $16616 | -$531 | -$1157 |
| Total shareholder equity | $18593 | $16616 | $14877 | $13084 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5494 | $5422 | $5815 | |
| Cost of revenue | $2006 | |||
| Gross Profit | $3515 | $3416 | $3713 | |
| Operating activities | ||||
| Research & development | $363 | |||
| Selling, general & administrative | $1847 | |||
| Total operating expenses | $2322 | $2365 | $2278 | |
| Operating income | $1051 | |||
| Income from continuing operations | ||||
| EBIT | $998 | |||
| Income tax expense | $209 | $173 | $83 | |
| Interest expense | $30 | |||
| Net income | ||||
| Net income | $834 | $825 | $1143 | |
| Income (for common shares) | $825 | |||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20498 | $18449 | $14351 | |
| Cost of revenue | $6871 | $5294 | ||
| Gross Profit | $13099 | $11578 | $9057 | |
| Operating activities | ||||
| Research & development | $1454 | $984 | ||
| Selling, general & administrative | $6455 | $5361 | ||
| Total operating expenses | $8779 | $8737 | $6834 | |
| Operating income | $2841 | $2223 | ||
| Income from continuing operations | ||||
| EBIT | $2683 | $1954 | ||
| Income tax expense | $508 | $325 | $355 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $3165 | $2358 | $1599 | |
| Income (for common shares) | $2358 | $1599 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $825 | $788 | ||
| Operating activities | ||||
| Depreciation | $103 | $107 | ||
| Business acquisitions & disposals | -$88 | -$246 | ||
| Stock-based compensation | $46 | $87 | ||
| Total cash flows from operations | $633 | $204 | ||
| Investing activities | ||||
| Capital expenditures | -$152 | -$167 | ||
| Investments | $93 | $5 | ||
| Total cash flows from investing | -$2697 | -$117 | -$408 | -$962 |
| Financing activities | ||||
| Dividends paid | -$914 | -$305 | -$304 | -$1139 |
| Sale and purchase of stock | ||||
| Net borrowings | -$599 | -$1 | ||
| Total cash flows from financing | $1269 | -$966 | -$418 | -$1594 |
| Effect of exchange rate | -$4 | -$6 | -$19 | -$28 |
| Change in cash and equivalents | $879 | -$456 | -$641 | $1096 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2358 | $1994 | $1599 | |
| Operating activities | ||||
| Depreciation | $371 | $371 | $340 | |
| Business acquisitions & disposals | -$2563 | -$339 | -$4222 | |
| Stock-based compensation | $168 | $171 | $142 | |
| Total cash flows from operations | $2624 | $3263 | $3277 | |
| Investing activities | ||||
| Capital expenditures | -$588 | -$525 | -$487 | |
| Investments | $188 | $6 | $7 | |
| Total cash flows from investing | -$962 | -$2924 | -$859 | -$4701 |
| Financing activities | ||||
| Dividends paid | -$1139 | -$1051 | -$950 | -$863 |
| Sale and purchase of stock | ||||
| Net borrowings | $472 | -$1153 | $989 | |
| Total cash flows from financing | -$1594 | -$749 | -$2365 | -$11 |
| Effect of exchange rate | -$28 | -$51 | -$38 | $41 |
| Change in cash and equivalents | $1096 | -$1100 | $1 | -$1394 |
News
Fundamentals
| Market cap | $131.82B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 381.20M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 11.92% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.14 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.91 |
| Quick ratio | 1.22 |